Clinical Trials Directory

Trials / Completed

CompletedNCT03503877

Media, Morphokinetics, and Mosaicism

Aneuploidy Rates and Morphokinetic Parameters in Sibling Embryos Cultured in Distinct Culture Media

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
Female
Age
18 Years – 42 Years
Healthy volunteers
Accepted

Summary

Embryonic aneuploidy is the underlying etiology for the majority of failed implantation and miscarriage. Preimplantation genetic screening (PGS) with transfer of a euploid embryo has been advocated as a strategy for increasing live birth rates with a single embryo transfer. Culturing embryos to the blastocyst stage for trophectoderm biopsy is a requirement for PGS. Several commercially-available single-step embryonic culture media with varying composition have been established for use in the IVF laboratory. Early reports have suggested differences in clinical outcomes, such as aneuploidy and miscarriage rates, with distinct culture media currently in standard use. However, there have been no clinical trials demonstrating the superiority of any one commercially-available culture media formulation. As a result, clinics use media with varying composition based upon familiarity and cost.

Conditions

Interventions

TypeNameDescription
DEVICEEmbryoScope PlusAll embryos will be cultured in the EmbryoScope Plus to obtain morphokinetic data
OTHERGLOBAL MEDIAEmbryos will be cultured in GLOBAL media
OTHERSAGE MEDIAEmbryos will be cultured in SAGE media

Timeline

Start date
2018-02-14
Primary completion
2019-11-28
Completion
2019-11-28
First posted
2018-04-20
Last updated
2022-12-14
Results posted
2022-12-14

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03503877. Inclusion in this directory is not an endorsement.